| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| East India Pharmaceutical Works Limited |
BALANCE SHEET OF EAST INDIA PHARMACEUTICAL WORKS LIMITED (In Rs.) (As of 31-03-2019 to 31-03-2021)
|
PARTICULARS |
2021 |
2020 |
2019 |
|
EQUITY AND LIABILITIES: |
|||
|
Share Capital |
6,67,45,179 |
6,67,45,179 |
6,67,45,179 |
|
Reserves and Surplus |
40,56,16,066 |
38,08,35,247 |
36,48,10,162 |
|
Minority Interest |
(45,888) |
(45,738) |
(45,635) |
|
Non-Current Liabilities: |
|||
|
Long-Term Borrowings |
4,23,36,281 |
32,67,440 |
12,40,426 |
|
Long-Term Provisions |
8,14,91,000 |
6,43,20,000 |
5,51,46,000 |
|
Current Liabilities: |
|||
|
Short-Term Borrowings |
32,19,00,853 |
35,31,62,674 |
31,40,23,439 |
|
Trade Payables |
34,39,64,616 |
34,94,48,075 |
30,64,48,374 |
|
Other Current Liabilities |
19,62,03,669 |
17,44,73,972 |
17,31,13,522 |
|
Short-Term Provisions |
3,35,77,000 |
1,65,09,000 |
90,90,000 |
|
TOTAL LIABILITIES |
1,49,17,88,776 |
1,40,87,15,849 |
1,29,05,71,467 |
|
ASSETS |
|||
|
Non-Current Assets |
|||
|
Fixed Assets |
|||
|
Tangible Assets |
15,41,09,850 |
17,06,81,797 |
9,63,38,731 |
|
Intangible Assets |
7,82,364 |
8,26,060 |
9,34,088 |
|
Capital work-in-progress |
37,32,327 |
66,27,594 |
9,78,80,503 |
|
Deferred Tax Assets (Net) |
4,89,77,722 |
4,23,80,405 |
3,78,16,137 |
|
Long-Term Loans and Advances |
71,16,873 |
1,00,86,375 |
90,98,712 |
|
Current Assets |
|||
|
Inventories |
34,94,30,415 |
37,83,84,071 |
26,87,61,911 |
|
Trade Receivables |
70,98,01,337 |
57,00,98,674 |
53,42,38,157 |
|
Cash and Cash Equivalents |
15,67,73,363 |
12,68,82,571 |
16,89,35,815 |
|
Short-Term Loans and Advances |
6,10,64,525 |
10,07,48,302 |
7,45,67,413 |
|
Other Current Assets |
NIL |
20,00,000 |
20,00,000 |
|
TOTAL ASSETS |
149,17,88,776 |
140,87,15,849 |
129,05,71,467 |
PROFIT & LOSS STATEMENT OF EAST INDIA PHARMACEUTICAL WORKS LIMITED (In Rs.)
(As of 31-03-2019 to 31-03-2021)
|
Particular |
2021 |
2020 |
2019 |
|
Revenue |
|||
|
Revenue from Operations |
1,72,67,84,326 |
1,58,39,11,504 |
1,61,28,72,834 |
|
Other Income |
1,80,260 |
15,71,901 |
12,35,696 |
|
Total Revenue |
1,72,69,64,586 |
1,58,54,83,405 |
1,61,41,08,530 |
|
Expenses |
|||
|
Cost of materials consumed |
49,96,34,132 |
46,57,72,212 |
45,62,48,199 |
|
Purchases of Traded Goods |
1,71,87,443 |
1,77,56,384 |
1,26,64,335 |
|
Finished goods, Work-in-Progress, and Traded Goods |
2,83,85,036 |
(4,58,18,931) |
(1,19,97,983 |
|
Employee Benefits Expenses |
63,98,08,743 |
59,20,38,256 |
54,00,90,712 |
|
Finance Costs |
5,05,30,470 |
5,55,92,371 |
5,69,63,781 |
|
Depreciation and Amortisation Expenses |
2,60,54,248 |
3,03,52,719 |
1,63,96,508 |
|
Research and Development Expenses |
1,35,43,417 |
1,36,07,606 |
1,18,54,490 |
|
Other Expenses |
39,67,63,227 |
42,54,57,542 |
51,58,75,286 |
|
Total Expenses |
1,67,19,06,716 |
1,55,47,58,159 |
1,59,80,95,328 |
|
Profit / (Loss) Before Tax |
5,50,57,870 |
3,07,25,246 |
1,60,13,202 |
|
Tax Expenses |
|||
|
Current tax |
2,50,00,000 |
1,00,00,000 |
45,00,000 |
|
Deferred tax |
(65,97,317) |
(45,64,268) |
(26,25,388) |
|
Tax Adj. of earlier Years |
51,99,659 |
52,41,291 |
14,72,927 |
|
Total |
2,36,02,342 |
1,06,77,023 |
33,47,539 |
|
Profit / (Loss) For the Year |
3,14,55,528 |
2,00,48,223 |
1,26,65,663 |
|
Earnings Per Equity Shares |
|||
|
Earnings Per Equity Shares (Basic) |
4.71 |
3.00 |
1.90 |
|
Earnings Per Equity Shares (Diluted) |
4.71 |
3.00 |
1.90 |
DIVIDEND AND RETAINED EARNINGS (As of 31-03-2019 to 31-03-2021)
|
Particulars |
2021 |
2020 |
2019 |
|
Dividend (in Rs.) |
1.25 |
1.00 |
0.50 |
|
Retained Earnings |
248.11 |
160.46 |
126.77 |
PERFORMANCE OF THE COMPANY
